Table 2.
PDI | p-value | IDV | p-value | MAS | p-value | UIA | p-value | LTO | p-value | |
SAR Self-medication (N = 17) | 0.54 | 0.026 | -0.41 | 0.104 | 0.31 | 0.228 | 0.43 | 0.086 | -0.12g | 0.722 |
SAR Prescribed use (N = 17) | 0.59 | 0.012 | -0.45 | 0.072 | 0.42 | 0.094 | 0.32 | 0.208 | -0.02g | 0.958 |
ESAC (N = 24) | 0.59 | 0.003 | -0.29 | 0.166 | 0.22 | 0.308 | 0.59 | 0.003 | -0.13h | 0.620 |
Eurobarometer (N = 15) | 0.62 | 0.014 | -0.30 | 0.280 | 0.31 | 0.259 | 0.57 | 0.025 | -0.39i | 0.190 |
Controlled for GDP/capita | ||||||||||
SAR Self-medication (N = 17) | 0.23 0.41 | 0.615 | -0.03 0.10 | 0.948 | 0.61 0.58 | 0.150 | 0.19 0.26 | 0.683 | 0;00g | 0.998 |
SAR Prescribed use (N = 17) | 0.362 | 0.831 | 0.172 | 0.572 | -0.01g | 0.977 | ||||
ESAC (N = 24) | 0.72 | 0.067 | 0.09 | 0.851 | 0.38 | 0.395 | 0.55 | 0.206 | -0.07h | 0.887 |
Eurobarometer (N = 15) | 0.50 | 0.249 | 0.10 | 0.834 | 0.81 | 0.027 | 0.50 | 0.252 | -0.50i | 0.255 |
g) based on 11 cases
h) based on 18 cases
i) based on 13 cases